Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. In mammalian kidney, the proximal convoluted tubule (PCT) is the main site of arginine (Arg) production. Arginine can be used in the biosynthesis of guanidino compounds (GC). Since uremic rats have a lower functional mass of PCT, GC synthesis might be modified, especially that of guanidinoacetic acid (GAA) which occurs in PCT. In order to study GC metabolism at different steps of uremia, rats were subjected to either 42% or 80% nephrectomy (NX); the experiment lasted for three weeks. Results show that: (1) in plasma, the pattern of GC levels in 42% NX rats was similar to that of controls except for a clear increase of -guanidinopropionic acid (13-GPA), whereas in 80% NX rats, all GC levels sharply increased except that of creatine which decreased. (2) Urinary excretion of GC in control and 42% NX rats is quite similar except for GAA which strongly decreased, and for homoarginine (HArg) and argininic acid (ArgA) which increased. In rats with 80% NX, the principal modification in GC excretion was a four-to five-fold reduction in GAA output. (3) After induction of renal failure, Arg, creatine and guanidinosuccinic acid reabsorption remained unchanged, and that of HArg decreased. For guanidine and methylguanidine the negative renal balance remained unchanged, and that of y-guanidinobutyric acid, GAA and cs-keto-b-guanidinovaleric acid became smaller, suggesting a better reabsorption. In conclusion, uremia strongly modified GC metabolism involving mainly those synthesized from Arg; both GAA and creatine synthesis were strongly decreased probably because of the loss of renal tissue, mainly PCT.
compounds such as -guanidinopropionic acid (f3-GPA), y-guanidinobutyric acid (y-GBA) and a-keto-h-guanidinovaleric acid (a-keto-b-GVA).
Arginine, a basic amino acid, can be synthesized in the kidney, released in the bloodstream and become available for the different metabolic needs of the body [2, 3] . Recently, the sites of arginine metabolism have been identified along the nephron. Levillain et a! [4, 5] have reported that, in mammalian kidney, the proximal convoluted tubule is the main site of arginine synthesis. Its early part near the glomerulus, namely the Si [61,produces the highest amounts of arginine. On the other hand, Takeda et al [7] [8] [9] have shown that guanidinoacetic acid synthesis, which requires arginine and glycine [10] , is also localized in the early part of the proximal convoluted tubule (Si). Furthermore, guanidinoacetic acid is the precursor of creatine, creatine phosphate and creatinine. It has also been found that creatinine is the precursor of methylguanidine in liver [ii] . Therefore, the contribution of the kidney to guanidino compound synthesis is considerable and fulfills the arginine and GAA needs of other organs under normal physiological conditions. Alteration of the renal function by disease and nephrotoxic drugs, which destroy the cells of the proximal tubule, or by experimental surgery (model of 5/6 nephrectomy), might modify the metabolism of the different guanidino compounds mainly in the kidney and the liver [12] . Guanidine, methylguanidine and GSA, are found to be increased in uremia [13] [14] [15] and shown to be potential toxins [16] [17] [18] [19] [20] [21] [22] .
We decided to investigate the metabolism of guanidino compounds and some physiological functions of the kidney in animals with induced renal insufficiency. Therefore, concentrations of guanidino compounds were measured in plasma and in urine of rats as well as other biochemical parameters varying with the degree of renal failure. The functional kidney mass was reduced by ligation of several branches of the renal arteries leading to the well known 5/6 nephrectomy model. In this study, we induced nephrectomy (NX) by renal ablation varying from 20% to 90%.
This work permitted us: (1) to collect new data on the plasma levels and the urinary excretion of 12 guanidino compounds in both normal and uremic rats; (2) to establish, for each guanidino compound, correlations between plasma levels or urinary excretion levels and the degree of renal insufficiency; and (3) to investigate the movements of the guanidino compounds in the kidney.
Methods
Levillain et a!: Guanidino compounds in renal insufficiency 465 Calculations Animals Male Sprague-Dawley rats (Iffa Credo, France) weighing 200 to 220 g were used for this study. Rats were divided at random into three groups before inducing renal injury by ligating branches of the renal arteries as proposed in the model of 5/6 ncphrectomy which induces severe renal damage.
Rats were anesthetized with pentobarbital (Nembutal 6%, 0.1 ml per 100 g body wt, i.p.). In the first group control rats were sham operated. In the second group, rats were subjected to a reduction of the functional renal mass, which varied from 30% to 50%, by either ligating branches of the right renal artery (less than 50% NX) or removing the right kidney (50% NX). In the third group, nephreetomy of the right kidney and ligating branches of the left renal artery resulted in approximately 70% to 90% NX.
The rats were housed individually for three weeks and had free access to tap water and standard chow (M25 Extralabo, France). Before sacrifice, most of the rats were kept in a metabolic cage for an adaptative period and had free access to tap water and powder of M25 chow. Three days later, urine was collected during a period of 24 hours.
Collection of blood and urine samples
The rats were anesthetized with 0.1 ml pentobarbital per 100 g body wt. Samples of arterial blood were taken from the abdominal aorta and transferred into lithium heparinized vacutainer tubes which were maintained at 4°C. Then, the blood samples were centrifuged at 4,000 g for 20 minutes at 4°C and a fraction of the plasma was frozen at -50°C until determination of guanidino compound concentration. In the other fraction, both urea and creatinine were measured on an Astra 8 Beckman analyzer.
Urines collected during 24 hours before sacrifice were centrifuged at 4,000 g for 20 minutes at 4°C and the volume of urine was measured. Samples of urine were frozen at -50°C until determination of the guanidino compounds, whereas, in other samples, osmolality was determined with a freezing-point osmometer (Fiske, Uxbridge); urea was measured on a Technieon SMA 6 and creatinine was determined by a modified Jaffe method. The remaining kidney(s) were removed and weighed.
Determination of the guanidino compounds
For the guanidino compound (GC) determination, plasma and urine were deproteinized by mixing equal volumes of a 200 g/liter triehloroacetic acid solution with the sample. The samples were centrifuged (8,000 g) in a Beckman mierofuge for five minutes (Beckman Instruments, Fullerton, CA, USA). Clear supernatant was diluted with 0.02 N HC1 and used for guanidino compound analysis in urine; 200 gl supernatant was used for the determinations in plasma.
The concentration of the guanidino compounds was determined using a Biotronie LC 5001 (Biotronik, Maintal, Germany) amino acid analyzer adapted for guanidino compound determination. The guanidino compounds were separated over a cation exchange column using sodium citrate buffers and were detected with the fluorescence ninhydrin method as has been reported in detail earlier [231.
Estimation of the nonfunctional renal mass. The degree of necrosis was deduced "de visu" during the surgical step by estimating the importance of the damage following the ligature of the branches of the renal artery as described earlier [24, 25] .
Immediately, there was an isehemia and the corresponding renal area which was irrigated by the ligated arteriole became darker than the nonisehemie area. This permitted evaluation of the fraction of the impaired tissue as compared to the total renal mass. A value of 50% NX when one kidney was removed was attributed because, in control rats, the mass of the right kidney did not differ from that of the left kidney (unpublished data); Kaufman et al have observed the same [24] .
Calculation of glomerular filtration rate. Although inulin clearance has been recognized to be one of the best methods to measure the glomerular filtration rate (GFR), in our experimental protocol, GFR was calculated by using the creatinine clearance for practical reasons.
Since guanidino compounds were measured in plasma and urine and since the GFR was known, it was possible to study the renal balance (B) for each guanidino compound. In order to know the balance, the amounts of GC which were filtered (entry) and excreted (exit) per day were calculated by using the following equation:
where [GC] represents the concentration of one guanidino compound in the plasma or urine, V is the volume of urine collected during 24 hours and 1440 is the time expressed in minutes per day. This calculation cannot give detailed information on the possible reabsorption, renal synthesis, concentration in the renal medulla or excretion along the nephron, but B value indicates the resulting movement of the guanidino compounds. If the sign of the value is positive globally it reflects that a GC is reabsorbed, whereas if the sign is negative, it means that the amount excreted is higher than the amount filtered.
Statistical analysis
In Tables, the results are presented as mean SE. The data obtained in the control and experimental group of rats were compared by the analysis of variance (ANOVA, Statview II SE) and the Fisher test to determine the P value at the 95% and 99% levels of significance. For the correlation analysis, the coefficient r was calculated and the P value was determined from the table of correlation at the level 95% of significance.
Results

General observations
Results summarized in Table 1 show some biological parameters which have been measured or calculated.
The mean body weight of controls and uremie rats was not statistically different. In rats with either 42% or 80% NX, in spite of the renal compensatory growth, the remaining kidney weight was respectively 9% and 42% lower than the control. Results are mean SE of (N) rats in groups 1, 2 and 3, respectively. Results were statistically analyzed by ANOVA one Factor, Fisher PLSD. Abbreviations are: U, urine; P, plasma; Osm, osmolality; GFR, glomerular filtration rate; NX, nephrectomy; Cr, creatinine. "P < 0.05 and b P < 0.01 vs. control group P < 0.01 group 3 vs. group 2 Table 2 . Plasma guanidino compound levels in control and uremic rats Results are mean SE (jrmol/liter) of 10, 21 and 14 rats in groups 1, 2 and 3, respectively. Results were statistically analyzed by ANOVA one Factor, Fisher PLSD.
Abbreviations are: NX, nephrectomy; GC, guanidino compounds. The levels of a-N-acetylarginine could not be determined in plasma since an unknown guanidino compound is eluted very close to a-N-acetylarginine. This unknown peak is not seen in urine.
"P < 0.05 group 3 vs. group 2 b P < 0.01 vs. control "P < 0.01 group 3 vs. group 2
Urine volume was increased by 38% in rats with 42% NX and osmolality was decreased by 13%; thus, the amount of osmoles excreted daily was higher than in the control group (28.3 1.0 mOsm/day vs. 23.7
1.3 mOsm/day, respectively, P < 0.05). In rats with 80% NX, the variations were more pronounced: urinary volume was increased by 120% and the osmolality was decreased by 48% as compared to the control group. The daily amount of osmoles excreted was 25.4 1.6 (X 10) and did not differ from that measured in the other groups.
A weak increase of uremia and creatininemia was observed in rats with 42% NX, whereas they were sharply increased in rats with 80% NX ("'"2-fold higher).
From these data, GFR was calculated by the clearance of creatinine. Variations of GFR were very low in rats with 42% NX and did not differ statistically from the controls. In rats with 80% NX, GFR was reduced by 51% since more glomeruli were nonfunctional.
Pattern of guanidino compounds in plasma
Results presented in Table 2 show the pattern and the concentration of guanidino compounds in plasma in both control and uremic rats. Three weeks after the surgery, the total GC concentration measured in control rats did not differ from that in rats with 42% NX. In rats with about 5/6 nephrectomy (""80% NX) the total concentration of guanidino compounds was lower when compared to the levels in rats with 42% NX. This is explained by the sharp decrease in creatinemia of rats with severe renal damage (group 3). Omission of creatine in this calculation indicates that, in rats of group 3, plasma concentration of guanidino compounds was significantly increased as compared to that of groups 2 and 1.
The results clearly prove that the increase of guanidino compounds in plasma is not proportional to the degree of renal damage since the elevation of GC concentration is several-fold higher in rats with 80% NX than in rats with 42% NX.
In rats with 42% NX (Table 2) , the concentration of /3-guanidinopropionic acid (which was undetectable in control rats and at the same final level in rats of groups 2 and 3) was significantly increased (P < 0.01).
In rats with severe renal damage (80% NX), the concentration of most of the guanidino compounds was several-fold higher than in groups 1 and 2. Figure 1 A to E indicates that the concentration of a-keto-5-GVA, y-GBA, G, MG and GSA was exponentially increased. In parallel, the same exponential increase in urea and creatinine were observed in the plasma of rats with 80% nephrectomy (not shown). Creatine is the only compound which was decreased by 40 to 50% as compared to the other groups (P < 0.01; Fig. iF) .
The plasma arginine and homoarginine levels were not modified in rats with nephrectomy.
Pattern of guanidino compounds in urine
A detailed analysis of the guanidino compounds excreted in urine of control rats shows that creatinine was quantitatively excreted the most, whereas the excretion of GAA and creatine was about seven-to ninefold lower. The other guanidino compounds (y-GBA, Arg, G and MG) were excreted in low amounts whereas traces of a-N-AA, ArgA and HArg were found in urine.
The mean amount of each GC excreted in urine during 24 hours is given in Table 3 . In rats with 42% NX, urinary excretion of most of the guanidino compounds remained statistically unchanged. However, urinary excretion of GAA was 32% lower as compared to the controls (Table 3 ). In contrast, urinary excretion of ArgA and I-IArg were significantly increased by 23% and 52%, respectively, as compared to the controls.
In rats with 80% NX, excretion of a-keto--GVA, CT, GAA, cs-N-AA, and Arg was significantly decreased, whereas the amounts of GSA, HArg, G and MG excreted per day were increased in a statistically significant manner as compared to groups 1 and 2 ( Table 3 and Fig. 2) . In contrast, excretion of y-GBA and ArgA were not modified. Excretion of GAA, a good marker of renal injury, was five-fold lower than in controls; in the Results are mean SE (imol/day) of 7, 16 and 9 rats in groups 1, 2 and 3, respectively. Results were statistically analyzed by ANOVA one Factor, Fisher PLSD.
Abbreviations are: NX, nephrectomy; GC, guanidino compounds; Cr, creatinine.
ap < 0.05 and bp < 0.01 vs. control P < 0.05 and dp < 0.01 group 3 vs. group 2 same way, creatine was nearly 13-fold lower than in the controls ( Table 3 and Fig. 2 A, B) .
Creatinine was the most excreted guanidino compound in urine, and the amounts excreted daily were in the same range in the three groups of rats. When calculating the total amount of GC excreted per day, except creatinine, the sum of GAA and CT represented 76%, 65% and 30% of GC in controls, 42% NX and 80% NX rats, respectively. This suggests that the metabolic pathway of GAA and CT is strongly modified and the more important the degree of nephrectomy, the lower the synthesis of both GAA and CT becomes ( Table 3 ).
It is noteworthy that when renal tissue is destroyed (for example, in uremia), the urinary excretion of those guanidino compounds that are mainly synthesized in kidney like Arg and GAA, and consequently their metabolites like CT, decreased. On the other hand when organs other than the kidneys are involved in the GC synthesis, urinary excretion of these GC either increased or remained unchanged ( Fig. 2 and Table 3 ).
Renal balance of guanidino compounds The daily amounts of GC filtered by the kidney are presented in Table 4 . Briefly, the results show that about 1.2 to 1.3 mmoles of GC were filtered per day in both controls and rats with 42% NX, whereas it was divided by two in 80% NX rats. In rats of group 2, the amounts of each GC filtered per day did not differ from the controls. In rats with severe renal damage (group 3), a-keto--GVA, CT, GAA, Arg and HArg were less filtered; in the opposite, the amounts of GSA, y-GBA, and MG filtered were increased about 2.6-fold.
Using the equation given in the Methods section, in control rats GSA, CT, Arg and I-IArg were calculated to be reabsorbed. As previously demonstrated by Bergeron et al [18, 26] , Arg was totally reabsorbed (99.9%); a similar conclusion can be proposed for HArg. In contrast to creatinine which was excreted, creatine, a compound which has a similar chemical structure, was nearly entirely reabsorbed (98%). About 16% of the filtered GSA was reabsorbed in controls. After induction of renal failure, Arg, GSA and CT reabsorption remained unchanged. In contrast, reabsorption of HArg was proportionally decreased to the degree of renal failure (Fig. 3D) . In nephrectomized rats, no traces of p-GPA were found in urine in spite of its high plasma concentration. This suggests that f3-GPA filtered was either totally reabsorbed or metabolized in the kidney.
Also, the amount of a-keto-6-GVA, GAA, y-GBA, G and MG excreted in urine of control rats was higher than the amount of these compounds filtered. After nephrectomy, the negative balance became smaller for a-keto-b-GVA, GAA, y-GBA ( Fig. 3 A,  B , C) and could even become positive. This is illustrated in rats with 80% nephrectomy where GAA was mainly reabsorbed. The negative balance for G and MG remained unchanged after induction of renal failure.
Discussion
In plasma of rats with moderate renal failure (42%), our results indicate that the concentration of f3-GPA was statistically increased while urinary excretion of GAA, a well known marker of renal injury, was decreased by 32%. Such an increase in plasma 13-GPA concentration has been reported in uremic patients [271. The metabolic pathway for the biosynthesis of 13-GPA and its physiological role remain unclear. Moreover, /3-GPA has been reported to be a toxic compound [27, 28] . However, although the increase of /3-GPA is related to the onset of renal failure, it is not specific. Indeed, in fasted rats an increase of the plasma 13-GPA levels also has been found [231. Consequently, in rats with low NX, plasma guanidino compounds cannot be used to detect the onset of renal failure and GAA remains the best urinary marker.
Most of the data presented in Tables 2, 3 and 4 show that only a few guanidino compounds had significantly modified levels in plasma and urine of rats with moderate renal failure, meaning that only a few metabolic pathways were disturbed. In contrast, the composition of both plasma and urine of rats with severe renal damage (80% NX) exhibited important changes, suggesting that the metabolism of nearly all guanidino compounds was strongly affected. These results indicate that the biosynthesis of GSA is considerably increased in uremic rats. The data are consistent with those found in uremic patients by Cohen, Stein and Bonas [13] . Perez et al [12] discovered that the liver of uremic rats enhances its rate of GSA synthesis. The biochemical basis for the increased biosynthesis of GSA in uremia has been explained by Natelson and Sherwin [29] , who proposed that urea produced in the urea cycle could be recycled in a "guanidine cycle" in order to form GSA as an overflow product.
Concerning the metabolic pathway of GAA and CT, it is known that GAA is synthesized by transamidination from arginine to glycine in the proximal convoluted tubule [30] and is further converted into creatine (CT) mainly in the liver. In our uremic rats (80% NX), in spite of the renal hypertrophy of the cortical zone (which contains proximal convoluted tubules), the amounts of GAA synthesized were sharply decreased because the urinary excretion of this compound was reduced five-fold (Table 3 ). Thus, it seems that, in uremia, the kidney has a lower capacity to synthesize GAA than in control rats. Inouchi et al proposed that the total activity of the renal glycine amidino transferase is lower in uremic rats than in control rats [31] . In 5/6 nephrectomized rats, our results and those of Inouchi et al show that both plasma concentration and urinary excretion of creatine fall dramatically [31] . The same observation has been reported when the renal cortex was destroyed by aminosides [32] . Since renal GAA synthesis decreased, lower amounts of GAA will be available for the hepatic synthesis of creatine. We propose that the rate limiting step of hepatic synthesis of CT depends on GAA availability.
Probably to compensate the low GAA synthesis in rats with severe renal failure, about 55% of the amount of GAA filtered was reabsorbed ( Fig. 3) . In contrast, in control rats about 45% of the amount of GAA filtered was excreted ( Fig. 3) . Positive values mean a reabsorption whereas negative values mean that the amount excreted is higher than the amount filtered. N = 32 rats including 7 controls, 16 and 9 rats with 42% or 80% NX, respectively. Each closed dot represents a value for a rat, calculated as indicated above. Heavy lines are lines of To have a good indicator of the kidney function, we correlated GAA urinary excretion with the weight of the kidney as suggested by Cohen and Patel [33] . As depicted in Figure 4 , the more important the renal injury, the lower were GAA and CT synthesis and excretion per day. This kind of representation could be used to follow the evolution of renal damages.
Guanidine and methylguanidine are known to be toxic compounds which accumulate in body fluids, mainly in the intracellu-lar compartment where they exert their deleterious effects [14] . It has been demonstrated that MG induces a uremic-like syndrome when injected subcutaneously in dogs [14] . Our results indicate that G and MG synthesis were increased in uremic rats. Depending on the authors, results obtained in uremic patients are conflicting. On the one hand, Menichini and Giovannetti have reported that serum concentration of guanidine is correlated with creatininemia but its urinary excretion is not different when Inhibition of nitric oxide formation by MG has been recently confirmed by Hasan et al [37] . We focused on the results concerning the renal balance of the GC. From the data presented in Tables 3 and 4 , and by using the equation given in the Methods, we obtained a view on the resulting movement of each GC inside the kidney. In the three groups of rats, GSA, CT, Arg and HArg were mainly reabsorbed but not to the same extent. In contrast, the negative balance for y-GBA, a-keto--GVA and GAA in control rats indicates that the amount excreted is more important than that filtered ( Fig. 3 ), suggesting that an additional amount of these GC has been added to the luminal fluid of the nephron. One or more of the following hypotheses might be involved: (1) the GC might be concentrated in the renal inner medulla, as is known for urea and as has been recently demonstrated for amino acids [38, 39] . (2) Guanidino compounds might be synthesized in the proximal tubule as known for Arg and GAA or in the distal tubule. (3) Guanidino compounds might be transported from the blood into the cell and further secreted into the tubular lumen. Such a secretion has been reported for strong organic bases in mammalian kidney [40] . In nephrectomized rats, y-GBA, a-keto--GVA and GAA were more reabsorbed, but the mechanisms remained unexplained.
In conclusion, destruction of the renal tissue induces important changes in guanidino compound metabolism in the rat. In rats with 80% nephrectomy, plasma GC levels are sharply increased except for creatine. Urinary excretion and renal balance of the guanidino compounds are disturbed after the induction of renal failure.
of guanidinoacetic acid in isolated renal tubules. EurJ Clin Chem Clin Heavy lines are lines of regression and "r" is the coefficient of correlation; in each case, P < 0.01. compared to that of healthy subjects [34] . On the other hand, Stein et al have observed that urinary excretion of MG is increased but plasma concentration remains at the control level [15] . These data are somewhat inconsistent with ours. It is unclear whether this is due to species differences or to other unknown reasons. The higher production of MG in uremic rats or patients is compatible with the fact that creatinine might be the precursor of MG. In the presence of superoxyde radicals, hydrogen peroxyde and hydroxyl radicals, MG synthesis is enhanced whereas scavengers such as glutathione reduce this process [35] .
How might MG act as a toxin in the kidney or in other organs? One of the possible answers has been proposed by Taylor et al [36] , who compared the chemical structure of MG and LNG methylarginine (L-NMMA), a specific inhibitor of the nitric oxide synthase. The two molecules have a similar structure. Thus, MG might compete with arginine and act as a natural inhibitor. 
